Patents Assigned to Universität Zürich and ETH Zurich
  • Bioconjugates of antibodies and functionalized magnetic nanoparticles
    Patent number: 11827721
    Abstract: The present invention relates to the field of antibodies useful in therapy and diagnosis. It specifically discloses bioconjugates comprising one or more antibodies bound to functionalized, magnetic nanoparticles. These bioconjugates are useful in cancer therapy, particularly for removing circulating tumor cells. The invention further pertains to specific functionalized, magnetic nanoparticles and to the manufacturing of such bioconjugates and such functionalized, magnetic nanoparticles.
    Type: Grant
    Filed: February 25, 2019
    Date of Patent: November 28, 2023
    Assignee: Universität Zürich and ETH Zurich
    Inventors: Antoine Florent Herzog, Wendelin Jan Stark, Martin Zeltner, Beatrice Beck-Schimmer, Anja Zabel